Subclassifications Of Assets, Liabilities And Equities [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166256

Concept	As at 2022-12-31	As at 2021-12-31	As at 2020-12-31
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	176,000 EUR	122,000 EUR	—
Intangible assets and goodwill [abstract]
Intangible assets other than goodwill [abstract]
Intangible assets other than goodwill	3,607,000 EUR	2,944,000 EUR	—
Investments accounted for using equity method [abstract]
Investments accounted for using equity method	3,948,000 EUR	4,079,000 EUR	—
Trade and other non-current receivables [abstract]
Trade and other non-current receivables	1,447,000 EUR	1,714,000 EUR	—
Trade and other current receivables [abstract]
Trade and other current receivables	5,127,000 EUR	2,321,000 EUR	—
Categories of non-current financial assets [abstract]
Non-current financial assets	1,000,000 EUR	453,000 EUR	—
Cash and cash equivalents [abstract]
Cash and cash equivalents	43,457,000 EUR	50,012,000 EUR	64,399,000 EUR
Borrowings [abstract]
Non-current portion of non-current borrowings	747,000 EUR	109,000 EUR	—
Current borrowings and current portion of non-current borrowings [abstract]
Current borrowings	138,000 EUR	65,000 EUR	—
Non-current portion of non-current borrowings, by type [abstract]
Trade and other current payables [abstract]
Trade and other current payables	2,422,000 EUR	2,749,000 EUR	—
Issued capital [abstract]
Issued capital	140,000 EUR	129,000 EUR	—
Retained earnings [abstract]
Retained earnings	53,476,000 EUR	43,226,000 EUR	—
Miscellaneous equity [abstract]
Reserve of share-based payments	1,622,000 EUR	2,391,000 EUR	—
Net assets (liabilities) [abstract]
Assets	61,864,000 EUR	63,444,000 EUR	—
Liabilities	6,819,000 EUR	15,388,000 EUR	—
Net current assets (liabilities) [abstract]
Current assets	50,801,000 EUR	53,959,000 EUR	—
Current liabilities	5,772,000 EUR	14,978,000 EUR	—
Assets less current liabilities [abstract]